(1) DXC Technology (NYSE: DXC) today announced that it has completed the sale of DXC s healthcare provider software business to the privately held Dedalus Group, a leading European healthcare and diagnostic software company, which is creating a stronger global presence in the clinical IT areas of hospital information systems (HIS), primary and social care, integrated care and diagnostics. The transaction was previously announced in July 2020.
The sale of DXC s healthcare provider software business to Dedalus is consistent with DXC s strategy and focus on the Enterprise Technology Stack. DXC expects to receive net proceeds of about $450 million from the transaction. The completion of the sale of our healthcare provider software business strengthens our balance sheet and unlocks new value for our stakeholders, said Mike Salvino, President and CEO, DXC. I would like to thank our people who are moving on to the Dedalus Group for their commitment and contributions over the yea